Inhibitory effects of Eucommia ulmoides Oliv. Bark on scopolamine-induced learning and memory deficits in mice

Biomolecules and Therapeutics

Volumn 21, Issue 6, 2013, Pages 462-469

  Kwon, Seung Hwan ^a   Ma, Shi Xun ^a   Joo, Hyun Joong ^a   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; cAMP element binding protein; Eucommia ulmoides Oliv. Bark; Learning and memory; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DONEPEZIL; EUCOMMIA ULMOIDES EXTRACT; SCOPOLAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; EUCOMMIACEAE; FRONTAL CORTEX; HIPPOCAMPUS; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT TERM MEMORY; WORKING MEMORY;

EID: 84888786000     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.074     Document Type: Article

References (37)

1. Alberini, C. M. (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol. Rev. 89, 121-145.
2. Annunziato, L., Amoroso, S., Pannaccione, A., Cataldi, M., Pignataro, G., D'Alessio, A., Sirabella, R., Secondo, A., Sibaud, L. and Di Renzo, G. F. (2003) Apoptosis induced in neuronal cells by oxida-tive stress: role played by caspases and intracellular calcium ions. Toxicol. Lett. 139, 125-133.
3. Bartus, R. T., Dean, R. L., 3rd, Beer, B. and Lippa, A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
4. Beatty, W. W., Butters, N. and Janowsky, D. S. (1986) Patterns of memory failure after scopolamine treatment: implications for cho-linergic hypotheses of dementia. Behav. Neural Biol. 45, 196-211.
5. Becker, R., Giacobini, E., Elble, R., McIlhany, M. and Sherman, K. (1988) Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration. Acta Neurol. Scand. Suppl. 116, 19-32.
6. Ben-Barak, J. and Dudai, Y. (1980) Scopolamine induces an increase in muscarinic receptor level in rat hippocampus. Brain Res. 193, 309-313.
7. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. and Davis, K. L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
8. Cheng, D. H. and Tang, X. C. (1998) Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol. Biochem. Behav. 60, 377-386.
9. Collerton, D. (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
10. El-Sherbiny, D. A., Khalifa, A. E., Attia, A. S. and Eldenshary Eel, D. (2003) Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol. Biochem. Behav. 76, 525-533.
11. Ellman, G. L., Courtney, K. D., Andres, V., Jr. and Feather-Stone, R. M. (1961) A new and rapid colorimetric determination of acetylcholin-esterase activity. Biochem. Pharmacol. 7, 88-95.
12. Fan, Y., Hu, J., Li, J., Yang, Z., Xin, X., Wang, J., Ding, J. and Geng, M. (2005) Effect of acidic oligosaccharide sugar chain on scopol-amine-induced memory impairment in rats and its related mechanisms. Neurosci. Lett. 374, 222-226.
13. Francis, P. T., Palmer, A. M., Snape, M. and Wilcock, G. K. (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66, 137-147.
14. Jeong, E. J., Lee, K. Y., Kim, S. H., Sung, S. H. and Kim, Y. C. (2008) Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur. J. Pharmacol. 588, 78-84.
15. Jia, Y., Gall, C. M. and Lynch, G. (2010) Presynaptic BDNF promotes postsynaptic longterm potentiation in the dorsal striatum. J. Neuro-sci. 30, 14440-14445.
16. Joseph, J. A., Strain, J. G., Jimenez, N. D. and Fisher, D. (1997) Oxidant injury in PC12 cells--a possible model of calcium dysregula-tion in aging: I. Selectivity of protection against oxidative stress. J. Neurochem. 69, 1252-1258.
17. Kempermann, G. (2008) The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for? Trends Neurosci. 31, 163-169.
18. Kim, D. H., Hung, T. M., Bae, K. H., Jung, J. W., Lee, S., Yoon, B. H., Cheong, J. H., Ko, K. H. and Ryu, J. H. (2006) Gomisin A improves scopolamine-induced memory impairment in mice. Eur. J. Pharmacol. 542, 129-135.
19. Komulainen, P., Pedersen, M., Hanninen, T., Bruunsgaard, H., Lakka, T. A., Kivipelto, M., Hassinen, M., Rauramaa, T. H., Pedersen, B. K. and Rauramaa, R. (2008) BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol. Learn. Mem. 90, 596-603.
20. Kopelman, M. D. and Corn, T. H. (1988) Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsa-koff syndrome. Brain 111 (Pt 5), 1079-1110.
21. Kwon, S. H., Kim, H. C., Lee, S. Y. and Jang, C. G. (2009) Loganin improves learning and memory impairments induced by scopolamine in mice. Eur. J. Pharmacol. 619, 44-49.
22. Kwon, S. H., Kim, M. J., Ma, S. X., You, I. J., Hwang, J. Y., Oh, J. H., Kim, S. Y., Kim, H. C., Lee, S. Y. and Jang, C. G. (2012) Eucommia ulmoides Oliv. Bark. protects against hydrogen peroxide-induced neuronal cell death in SH-SY5Y cells. J. Ethnopharmacol. 142, 337-345.
23. Kwon, S. H., Lee, H. K., Kim, J. A., Hong, S. I., Kim, H. C., Jo, T. H., Park, Y. I., Lee, C. K., Kim, Y. B., Lee, S. Y. and Jang, C. G. (2010) Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 649, 210-217.
24. Kwon, S. H., Lee, H. K., Kim, J. A., Hong, S. I., Kim, S. Y., Jo, T. H., Park, Y. I., Lee, C. K., Kim, Y. B., Lee, S. Y. and Jang, C. G. (2011) Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice. Neurosci. Lett. 487, 123-127.
25. LeDoux, J. E. (1993) Emotional memory systems in the brain. Behav. Brain Res. 58, 69-79.
26. Lee, M. K., Cho, S. Y., Kim, D. J., Jang, J. Y., Shin, K. H., Park, S. A., Park, E. M., Lee, J. S., Choi, M. S. and Kim, M. J. (2005) Du-zhong (Eucommia ulmoides Oliv.) cortex water extract alters heme biosynthesis and erythrocyte antioxidant defense system in lead-administered rats. J. Med. Food 8, 86-92.
27. Lovell, M. A., Ehmann, W. D., Butler, S. M. and Markesbery, W. R. (1995) Elevated thiobarbituric acid-reactive substances and anti-oxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
28. Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A. and Freedman, M. L. (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150, 40-44.
29. Mizuno, M., Yamada, K., Maekawa, N., Saito, K., Seishima, M. and Nabeshima, T. (2002) CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning. Behav. Brain Res. 133, 135-141.
30. O'Connell, C., Gallagher, H. C., O'Malley, A., Bourke, M. and Regan, C. M. (2000) CREB phosphorylation coincides with transient synapse formation in the rat hippocampal dentate gyrus following avoidance learning. Neural Plast. 7, 279-289.
31. Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A. and Winslow, J. W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695-702.
32. Sakurai, T., Kato, T., Mori, K., Takano, E., Watabe, S. and Nabeshima, T. (1998) Nefi racetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study. Neurosci. Lett. 246, 69-72.
33. Selkoe, D. J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
34. Singh, B., Bhat, T. K. and Singh, B. (2003) Potential therapeutic applications of some antinutritional plant secondary metabolites. J. Agric. Food Chem. 51, 5579-5597.
35. Wang, W., Sun, F., An, Y., Ai, H., Zhang, L., Huang, W. and Li, L. (2009) Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur. J. Pharmacol. 613, 19-23.
36. Yamada, K. and Nabeshima, T. (2003) Brain-derived neurotrophic fac-tor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267-270.
37. Yu, S. P., Canzoniero, L. M. and Choi, D. W. (2001) Ion homeostasis and apoptosis. Curr. Opin. Cell Biol. 13, 405-411.